Show simple item record

dc.contributor.authorNooka, Ajay K
dc.contributor.authorKaufman, Jonathan L
dc.contributor.authorRodriguez, Cesar
dc.contributor.authorJakubowiak, Andrzej
dc.contributor.authorEfebera, Yvonne
dc.contributor.authorReeves, Brandi
dc.contributor.authorWildes, Tanya
dc.contributor.authorHolstein, Sarah A
dc.contributor.authorAnderson, Larry D
dc.contributor.authorBadros, Ashraf
dc.contributor.authorShune, Leyla
dc.contributor.authorChari, Ajai
dc.contributor.authorPei, Huiling
dc.contributor.authorCortoos, Annelore
dc.contributor.authorPatel, Sharmila
dc.contributor.authorBartlett, J Blake
dc.contributor.authorVermeulen, Jessica
dc.contributor.authorLin, Thomas S
dc.contributor.authorRichardson, Paul G
dc.contributor.authorVoorhees, Peter
dc.date.accessioned2022-04-19T12:12:06Z
dc.date.available2022-04-19T12:12:06Z
dc.date.issued2022-04-13
dc.identifier.urihttp://hdl.handle.net/10713/18614
dc.description.urihttps://doi.org/10.1038/s41408-022-00653-1en_US
dc.language.isoenen_US
dc.publisherSpringer Natureen_US
dc.relation.ispartofBlood Cancer Journalen_US
dc.titleDaratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.en_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41408-022-00653-1
dc.identifier.pmid35418120
dc.source.journaltitleBlood cancer journal
dc.source.volume12
dc.source.issue4
dc.source.beginpage63
dc.source.endpage
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record